Constance A. Benson, MD
University of California San Diego
Professor of Medicine
San Diego, CA
Principal Investigator, UCSD HIV Collaborative Clinical Trials Unit
UCSD Antiviral Research Center
San Diego, CA
Dr Benson is Professor of Medicine, Senior Attending Physician in the Division of Infectious Diseases, Director of the Infectious Diseases Training Program, Director of the Antiviral Research Center, and the Principal Investigator of the CD4 Collaborative HIV Clinical Trials Unit at the University of California San Diego in San Diego, California, and President of the CROI Foundation. She is an internationally recognized researcher and clinician and has worked in the field of HIV/AIDS since 1984. Most recently her research has focused on the treatment and prevention of HIV-associated tuberculosis, the development of rapid point-of-care diagnostic assays for resource-limited settings, and new antiretroviral drug development.
(Updated July 18, 2024)
Judith S. Currier, MD
University of California Los Angeles
Professor of Medicine
Los Angeles, CA
Executive Vice Chair for Research, Department of Medicine
Director, UCLA-CDU Center for AIDS Research
Michael and Sue Steinberg Chair in Global AIDS Research
David Geffen School of Medicine
Carlos del Rio, MD
Emory University
Leon L. Haley, Jr MD Distinguished Professor of Medicine
Atlanta, GA
Executive Associate Dean for Faculty and Clinical Affairs
Roy M. Gulick, MD, MPH
Weill Cornell Medicine
Rochelle Belfer Professor in Medicine; Chief, Division of Infectious Diseases
New York, NY
Donna M. Jacobsen, BS
IAS–USA
Executive Director/President
San Francisco, CA
Executive Manager
Conference on Retroviruses and Opportunistic Infections (CROI)
San Francisco, California
Douglas D. Richman, MD
University Of California San Diego
Distinguished Professor of Pathology and Medicine, Active Emeritus
La Jolla, CA
Director, The HIV Institute
Co-Director, San Diego Center for AIDS Research
University Of California San Diego
La Jolla, CA
Michael S. Saag, MD
University of Alabama at Birmingham
Professor of Medicine, Emeritus
Birmingham, AL
Robert T. Schooley, MD
University of California San Diego
Professor of Medicine; Co-Director, Center for Innovative Phage Applications and Therapeutics
La Jolla, CA
Dr Schooley is a Distinguished Professor of Medicine in the Division of Infectious Diseases and Global Public Health at the University of California San Diego. He completed medical school, an internal medicine residency at Johns Hopkins, and infectious disease fellowships at the National Institutes of Health (NIH) and Massachusetts General Hospital. He joined the faculty of Harvard Medical School in 1981. His longer-term research efforts are directed at the pathogenesis and therapy of RNA virus infections. He has been heavily involved in the development of antiviral chemotherapy directed at HIV, HCV, and the herpesgroup viruses, as well as in research, teaching, and infrastructure building efforts in sub-Saharan Africa. Following his successful treatment of a multidrug resistant A. baumannii infection in a fellow faculty member at University of California San Diego, he has become interested in the use of viruses as therapeutic agents – namely, the use of bacteriophages to treat multidrug resistant bacterial infections. He currently serves as Co-Director of University of California San Diego’s phage research center (the Center for Innovative Phage Applications and Therapeutics, IPATH).
(Updated July 18, 2024)
